Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 66 results.
User Information
Export Records
  1. 1.   Identification of Structural and Morphogenesis Genes of Sulfitobacter Phage FGT1 and Placement within the Evolutionary History of the Podoviruses
  2. Hardies, Stephen C; Cho, Byung Cheol; Jang, Gwang Il; Wang,Jenny; Hwang, Chung Yeon
  3. Viruses. 2023, Jun 29; 15(7):
  1. 2.   Predicting Volume of Distribution in Humans: Performance of in silico Methods for A Large Set of Structurally Diverse Clinical Compounds
  2. Murad, Neha; Pasikanti, Kishore K; Madej,Benjamin; Minnich, Amanda; McComas, Juliet M; Crouch, Sabrinia; Polli, Joseph W; Weber, Andrew D
  3. Drug metabolism and disposition: the biological fate of chemicals. 2021, Feb 1; 49: 169-178.
  1. 3.   Crystal structures of beta-1,4-galactosyltransferase 7 enzyme reveal conformational changes and substrate binding
  2. Tsutsui, Y.; Ramakrishnan, B.; Qasba, P. K.
  3. Journal of Biological Chemistry. 2013, 1-Nov; 288(44): 31963-70.
  1. 4.   The interdomain linker region of HIV-1 capsid protein is a critical determinant of proper core assembly and stability
  2. Jiang, J. Y.; Ablan, S. D.; Derebail, S.; Hercik, K.; Soheilian, F.; Thomas, J. A.; Tang, S. X.; Hewlett, I.; Nagashima, K.; Gorelick, R. J.; Freed, E. O.; Levin, J. G.
  3. Virology. 2011, Dec; 421(2): 253-265.
  1. 5.   RNA polymerase III transcription in cancer: the BRF2 connection
  2. Cabarcas, S.; Schramm, L.
  3. Molecular Cancer. 2011, Apr; 10: 10.
  1. 6.   HCV Peptide (C5A), an Amphipathic alpha-Helical Peptide of Hepatitis Virus C, Is an Activator of N-Formyl Peptide Receptor in Human Phagocytes
  2. Lin, Q.; Fang, D.; Hou, X. W.; Le, Y. Y.; Fang, J. H.; Wen, F.; Gong, W. H.; Chen, K. Q.; Wang, J. M.; Su, S. B.
  3. Journal of Immunology. 2011, Feb; 186(4): 2087-2094.
  1. 7.   Inactivation of the FLCN Tumor Suppressor Gene Induces TFE3 Transcriptional Activity by Increasing Its Nuclear Localization
  2. Hong, S. B.; Oh, H.; Valera, V. A.; Baba, M.; Schmidt, L. S.; Linehan, W. M.
  3. Plos One. 2010, Dec; 5(12): 12.
  1. 8.   Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles
  2. Dobrovolskaia, M. A.; Patri, A. K.; Zheng, J. W.; Clogston, J. D.; Ayub, N.; Aggarwal, P.; Neun, B. W.; Hall, J. B.; McNeil, S. E.
  3. Nanomedicine-Nanotechnology Biology and Medicine. 2009 5(2): 106-117.
  1. 9.   Rb/Cdk2/Cdk4 triple mutant mice elicit an alternative mechanism for regulation of the G(1)/S transition
  2. Li, W.; Kotoshiba, S.; Berthet, C.; Hilton, M. B.; Kaldis, P.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(2): 486-491.
  1. 10.   Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms
  2. Satyanarayana, A.; Kaldis, P.
  3. Oncogene. 2009 28(33): 2925-2939.
  1. 11.   p21 inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint
  2. Satyanarayana, A.; Hilton, M. B.; Kaldis, P.
  3. Molecular Biology of the Cell. 2008 19(1): 65-77.
  1. 12.   Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation
  2. Berthet, C.; Klarmann, K. D.; Hilton, M. B.; Suh, H. C.; Keller, J. R.; Kiyokawa, H.; Kaldis, P.
  3. Developmental Cell. 2006, MAY; 10(5): 563-573.
  1. 13.   Oncogenic met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling
  2. Mood, K.; Saucier, C.; Ishimura, A.; Bong, Y. S.; Lee, H. S.; Park, M.; Daar, I. O.
  3. Journal of Cellular Physiology. 2006, APR; 207(1): 271-285.
  1. 14.   CB694, a novel antimitotic with antitumor activities
  2. Weiderhold, K. N.; Randall-Hiubek, D. A.; Polin, L. A.; Hamel, E.; Mooberry, S. L
  3. International Journal of Cancer. 2006, FEB 15; 118(4): 1032-1040.
  1. 15.   Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration
  2. Melcon, G.; Kozlov, S.; Cutler, D. A.; Sullivan, T.; Hernandez, L.; Zhao, P.; Mitchell, S.; Nader, G.; Bakay, M.; Rottman, J. N.; Hoffman, E. P.; Stewart, C. L.
  3. Human Molecular Genetics. 2006, FEB 15; 15(4): 637-651.
  1. 16.   P205, A potential, tumor suppressor, inhibits cell proliferation via multiple pathways of cell cycle regulation
  2. Asefa, B.; Dermott, J. M.; Kaldis, P.; Stefanisko, K.; Garfinkel, D. J.; Keller, J. R.
  3. Febs Letters. 2006, Feb; 580(5): 1205-1214.
  1. 17.   The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest
  2. Nagl, N. G.; Patsialou, A.; Haines, D. S.; Dallas, P. B.; Beck, G. R.; Moran, E.
  3. Cancer Research. 2005, OCT 15; 65(20): 9236-9244.
  1. 18.   Oligosaccharide preferences of beta 1,4-galactosyltransferase-I: Crystal structures of Met340His mutant of human beta 1,4-galactosyltransferase-I with a pentasaccharide and trisaccharides of the N-glycan moiety
  2. Ramasamy, V.; Ramakrishnan, B.; Boeggeman, E.; Ratner, D. M.; Seeberger, P. H.; Qasba, P. K.
  3. Journal of Molecular Biology. 2005, OCT 14; 353(1): 53-67.
  1. 19.   Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity
  2. Kong, D. H.; Park, E. J.; Stephen, A. G.; Calvani, M.; Cardellina, J. H.; Monks, A.; Fisher, R. J.; Shoemaker, R. H.; Melillo, G.
  3. Cancer Research. 2005, OCT 1; 65(19): 9047-9055.
  1. 20.   C/EBP beta cooperates with RB : E2F to implement Ras(V12)-induced cellular senescence
  2. Sebastian, T.; Malik, R.; Thomas, S.; Sage, J.; Johnson, P. F.
  3. Embo Journal. 2005, SEP 21; 24(18): 3301-3312.
  1. 21.   Albumin stimulates monocyte chemotactic protein-1 expression in rat embryonic mixed brain cells
  2. Calvo, C. F.; Amigou, E.; Tence, M.; Yoshimura, T.; Glowinski, J.
  3. Journal of Neuroscience Research. 2005, JUN 1; 80(5): 707-714.
  1. 22.   The B30.2(SPRY) domain of the retroviral restriction factor TRIM5 alpha exhibits line age-specific length and sequence variation in primates
  2. Song, B. W.; Gold, B.; O'HUigin, C.; Javanbakht, H.; Li, X.; Stremlau, M.; Winkler, C.; Dean, M.; Sodroski, J.
  3. Journal of Virology. 2005, MAY; 79(10): 6111-6121.
  1. 23.   Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKC delta-dependent increase in p27(Kip1) and decrease in retinoblastoma protein (pRb) phosphorylation
  2. Vucenik, I.; Ramakrishna, G.; Tantivejkul, K.; Anderson, L. M.; Ramljak, D.
  3. Breast Cancer Research and Treatment. 2005, MAY; 91(1): 35-45.
  1. 24.   Multidimensional separation of peptides for effective proteomic analysis
  2. Issaq, H. J.; Chan, K. C.; Janini, G. M.; Conrads, T. P.; Veenstra, T. D.
  3. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2005, MAR 5; 817(1): 35-47.
  1. 25.   In the quest for stable rescuing mutants of p53: Computational mutagenesis of flexible loop L1
  2. Pan, Y. P.; Ma, B. Y.; Venkataraghavan, R. B.; Levine, A. J.; Nussinov, R.
  3. Biochemistry. 2005, FEB 8; 44(5): 1423-1432.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel